UBS NASDAQ-100 ETF USD ACC
| Issuer: UBS |
| Asset Class: Equity |
| TER: 14bps |
| Trading Currency: GBX |
| Pays Income: False |
| Listing Date: 28 Mar 2025 |
| Ticker: QQQA |
| ISIN: IE000SB4G4I4 |
This fund offers targeted exposure to the 100 largest and most innovative non-financial companies listed on the Nasdaq Stock Market by tracking its benchmark index. The portfolio is heavily concentrated in the technology and consumer discretionary sectors, providing a direct investment into key global themes such as digital transformation, cloud computing, artificial intelligence, and e-commerce. Its holdings comprise many of the world's most recognizable and influential companies, making it a proxy for the cutting edge of the modern economy and a core component for investors seeking exposure to high-growth potential businesses.
As a growth-focused investment, this product is well-suited for investors with a higher risk tolerance and a long-term investment horizon. Its emphasis on innovation-driven companies offers the potential for significant capital appreciation, though this is often accompanied by higher volatility compared to more broadly diversified market indices. This particular share class is accumulating, meaning all dividend income from the underlying companies is automatically reinvested back into the fund. This process harnesses the power of compounding, which can substantially enhance overall returns over time and aligns perfectly with long-term wealth accumulation strategies.
The fund provides an efficient and cost-effective method to gain diversified access to a dynamic and critical segment of the U.S. equity market. It is an ideal choice for those aiming to capture the performance of leading technology and growth-oriented firms that are actively shaping the future of global industry. By holding a comprehensive basket of these pioneering companies in a single transaction, investors can bypass the complexities and expenses associated with individual stock picking while maintaining a strategic and significant allocation to innovation.
